We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$15M
AUM Growth
-$170M
Cap. Flow
-$69.6M
Cap. Flow %
-462.87%
Top 10 Hldgs %
51.84%
Holding
132
New
31
Increased
18
Reduced
10
Closed
70

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.45M
2
IHI icon
iShares US Medical Devices ETF
IHI
+$875K
3
RDCM icon
Radcom
RDCM
+$577K
4
APLS
Apellis Pharmaceuticals
APLS
+$491K
5
INSM icon
Insmed
INSM
+$431K

Top Sells

Rank Stock Value
1
MYO icon
Myomo
MYO
+$7M
2
ASPN icon
Aspen Aerogels
ASPN
+$6.96M
3
INDI icon
indie Semiconductor
INDI
+$4.63M
4
SCPH
scPharmaceuticals
SCPH
+$4.31M
5
TGAN
Transphorm, Inc. Common Stock
TGAN
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 29.82%
2 Technology 27.27%
3 Real Estate 20.31%
4 Communication Services 5.72%
5 Consumer Staples 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
W icon
126
PUT
Wayfair
W
$15.4B
– –
-46,700
Closed -$8.07K
SPRB
127
Spruce Biosciences
SPRB
$123M
– –
-7,026
Closed -$1.54M
VCNX
128
DELISTED
Vaccinex, Inc. Common Stock
VCNX
– –
-46,720
Closed -$435K
ALIM
129
DELISTED
Alimera Sciences
ALIM
– –
-556,642
Closed -$2.4M
TGAN
130
DELISTED
Transphorm, Inc. Common Stock
TGAN
– –
-1,153,778
Closed -$4.21M
KRTX
131
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-3,800
Closed -$293K
MDRX
132
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-120,400
Closed -$62.6K
2 3 4 5
6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Worth Venture Partners held 132 positions worth $15M, down 92% from $185M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Worth Venture Partners withdrew a net $69.6M in Q1 2024, closing 70 positions and reducing 10 holdings. Its most notable exit was Myomo, an estimated $7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 21% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Worth Venture Partners opened a new position in Johnson & Johnson worth $1.44M.

  • Worth Venture Partners's largest Q1 2024 buy was Johnson & Johnson: 9,100 shares worth $1.44M.
  • Worth Venture Partners added most to Arteris in Q1 2024, an estimated $185K increase.
  • Worth Venture Partners's biggest Q1 2024 reduction was scPharmaceuticals, cutting an estimated $4.31M.
  • Worth Venture Partners fully exited Myomo in Q1 2024, selling an estimated $7M.
  • Worth Venture Partners's ten largest holdings make up 52% of its $15M portfolio in Q1 2024.
  • Worth Venture Partners opened 31 new positions and closed 70 in Q1 2024.
  • Worth Venture Partners's portfolio value fell 92% quarter-over-quarter to $15M.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.